Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 917,700 | 606,100 | 566,300 | 642,300 | 1,052,600 |
| Marketable Securities | 1,081,000 | 1,973,300 | 2,157,800 | 1,813,900 | 1,678,600 |
| Receivables | 1,216,100 | 1,005,700 | 973,900 | 713,300 | 514,300 |
| Inventories | 629,100 | 542,600 | 559,600 | 306,700 | 357,300 |
| TOTAL | $4,033,300 | $4,301,400 | $4,425,900 | $3,668,800 | $3,684,400 |
| Non-Current Assets | |||||
| PPE Net | 1,559,900 | 1,339,900 | 1,113,100 | 1,055,600 | 801,800 |
| Intangibles | 95,000 | 126,200 | 159,700 | 199,000 | 58,000 |
| Other Non-Current Assets | 651,700 | 717,000 | 565,800 | 468,300 | 389,100 |
| TOTAL | $2,306,600 | $2,183,100 | $1,838,600 | $1,722,900 | $1,248,900 |
| Total Assets | $6,339,900 | $6,484,500 | $6,264,500 | $5,391,700 | $4,933,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 772,600 | N/A |
| Accounts payable and accrued liabilities | 1,944,000 | 1,585,100 | 1,345,500 | 901,800 | 573,000 |
| Accrued Expenses | 169,200 | 112,000 | 171,000 | 134,300 | 125,200 |
| Other current liabilities | 7,700 | 8,000 | N/A | N/A | N/A |
| TOTAL | $2,142,500 | $2,932,000 | $1,556,000 | $1,839,300 | $720,800 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,240,900 | 1,237,000 | 2,434,200 | 1,197,700 | 1,981,800 |
| Deferred Revenues | N/A | N/A | 18,400 | 10,100 | 2,100 |
| Other Non-Current Liabilities | 210,500 | 212,900 | 205,700 | 222,900 | 188,600 |
| TOTAL | $1,451,400 | $1,449,900 | $2,639,900 | $1,420,600 | $2,170,400 |
| Total Liabilities | $3,593,900 | $4,381,900 | $4,195,900 | $3,259,900 | $2,891,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 384,865 | 390,772 | 385,515 | 386,414 | 388,263 |
| Common Shares | 400 | 400 | 400 | 400 | 400 |
| Retained earnings | 2,433,900 | 1,597,600 | 1,021,400 | 479,900 | 138,700 |
| Other shareholders' equity | 115,200 | -8,200 | -16,800 | -11,600 | 300 |
| TOTAL | $2,746,000 | $2,102,600 | $2,068,600 | $2,131,800 | $2,042,100 |
| Total Liabilities And Equity | $6,339,900 | $6,484,500 | $6,264,500 | $5,391,700 | $4,933,300 |